Department of Critical Care Medicine, Auckland City Hospital
Auckland, New Zealand
Location contact
Christopher Hands
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07468266
The goal of this investigation is to examine the effect of nasal airflow in invasively ventilated adult patients following planned surgery. The main questions it aims to answer are:
* Does the investigational device produce an effect measured by EEG? * Are there differences in effect with modified airflow states?
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Auckland, New Zealand
Christopher Hands
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Provision of airflow to the nasal cavity by F&P Tui at baseline rate
Provision of airflow to the nasal cavity by F&P Tui at modified rate
Time frame: Before and 10 minutes after initiation of nasal airflow
Mean PSD will be calculated across beta, alpha, delta and gamma frequency bands
Time frame: 10 minutes after initiation of nasal airflow
Mean PSD will be calculated across beta, alpha, delta and gamma frequency bands and compared between TUI-1 and TUI-2
Time frame: Before and 10 minutes after initiation of nasal airflow
Inter-regional EEG coherence will be quantified as a measure of functional connectivity
Contact information is provided by the study sponsor or research team.
Fisher and Paykel Healthcare
Industry
Impacts of F&P Tui on Cortical Activity in Invasively Ventilated Post-operative Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07493785
Agnosia, Chemically-Induced Disorders
Brest, France
View Trial DetailsNCT05968066
Critical Illness, Disease Attributes
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT06592937
Invasive Ventilation
Amsterdam, Netherlands
View Trial DetailsNCT06589427
Invasive Ventilation
Amsterdam, Netherlands
View Trial Details